English     Spanish
    Casa
    Inscripción
    Alojamiento
    IVI Award
    Contáctenos
     Home
     Bienvenida
     Directiva
     Principales Temas y Objetivos
     Preliminary Program
     IVI Award
     Presentación de Abstracts
         Productíon de Posters
     Inscripción
     Alojamiento
     Accompanying Persons Program
     Patrocinio y Exposición
     Patrocinadores
     Media Partners
     Información General
     Sobre Madrid
     CME
     Invitation Letter
     Contáctenos
     IVI
3er Congreso Internacional IVI
Madrid, del 14 al 16 de mayo de 2009
  Preliminary Program Print
 
Ovarian stimulation
  • Current trends in poor responder management
    R. Fanchin (France)
  • The use of long-acting recombinant follicle-stimulation hormone for controlled ovarian stimulation
    N. Macklon (The Netherlands)
  • Factors predicting success in ovarian stimulation
    E. Bosch (Spain)
  • Modified natural cycle
    M. J. Pelinck (The Netherlands)
Minimal ovarian stimulation
  • Prediction models
    N. Macklon (The Netherlands)
  • Mild stimulation in poor responders
    J. H. Check (USA)
  • Debate : Mild stimulation
    J. Zhang (USA)
  • Debate: Conventional stimulation
    R. Fanchin (France)

Non-invasive assessment of oocytes and embryos

  • Metabolomics
    I. Sánchez (Spain)
  • Assessment of oocyte and embryo viability using Metabolomic profiling
    D. Sakkas (USA)
  • Respiration
    N. Ramsing (Denmark)
  • Imaging
    M. Montag (Germany)

Fertility preservation

  • Fertility preservation in pre-pubertal males
    H. Tournaye (Belgium)
  • Vitrification: Oocytes
    A. Cobo (Spain)
  • Vitrification of human zygotes and embryos
    S. Al-Hasani (Germany)
  • Freezing/drying of stem cells
    A. Arav (Israel)

Genetics and reproduction

  • Origin of human aneuploidies
    T. Hassold (USA)
  • The egg and the environment
    P. Hunt (USA)
  • Male meiosis
    F. Vidal (Spain)
  • Chromosomally abnormal human embryos
    L. Wilton (Australia)
  • Debate: Is PGS appropriate for embryo selection?
    PGS may be suitable for certain paitents to select embryos: J. Cohen (USA)
    PGS is not suitable for certain patients to select embryos: P. Devroey (Belgium)

Environmental challenges to reproductive health

  • Smoking
    S. Soares (Portugal)
  • Body weight
    J. Bellver (Spain)
  • Alcohol, caffeine and psychological stress
    H. Klonoff-Cohen (USA)
  • Pollutants , sedentarism, circadian rhythm
    E. Younglai (Canada)

New technologies that will impact clinical practice

  • Endometrial stem cells: Clinical relevance
    C. Gargett (Australia)
  • Generation of artificial gametes from stell cells
    C. Simon (Spain)
  • Maintenance of genetic integrity in embryos and stem cells
    J. McCarrey (USA)
     
  • Customized human embryonic stem cell (hESC) lines
    A. Krtolica (USA)
     
     

Polycystic ovarian syndrome

  • Intrauterine events and the risk of developing PCOS
    L. Ibañez (Spain)
  • Life style and health risks
    H. Escobar-Morreale (Spain)
  • In-vitro maturation (IVM) in PCO patients
    S. Tan (Canada)
  • Induction of ovulation in PCOS: is there are first line treatment?
    R. Legro (USA)

Poor prognosis patients and benign gynaecological diseases in ART

  • The influence of intramural fibroids
    A. Pellicer (Spain)
  • What should be done with endometriomas?
    A. Arici (USA)
  • Natural options in aged patients and low responders
    N. Laufer (Israel)
  • The role of oocyte vitrification in aged patients and low responders
    J. Crespo (Spain)

Luteal phase support

  • The need of luteal phase support in ART
    K. Diedrich (Germany)
  • Gonadotropin-releasing hormone (GnRH) agonist in IVF
    J. Tesarik (Spain)
  • Gonadotropin-releasing hormone (GnRH) agonist in intrauterine insemination (IUI)
    J. G. Velasco (Spain)
  • The use of corticosteroids and anabolic and androgenic steroids (AAS)
    P. Barri (Spain)

Copyright © 2007 comtecmed.com. All rights reserved. Created by     WebStudio.co.il